Professional and Reliable IHC Raw Antibody Solutions for Bladder Pathology
Bladder pathology often involves challenges in assessing urothelial differentiation and invasion. AREX supplies high-quality IHC raw antibodies supporting detection of epithelial markers, proliferation indicators, and other relevant targets to facilitate bladder cancer diagnosis and grading.
Core Advantages:
High specificity and low background suited to the complex staining environment of bladder tissue
Good sensitivity meeting needs across varying differentiation levels
Excellent batch-to-batch consistency for large-scale OEM supply
AREX bladder pathology raw antibodies integrate seamlessly with our
ARExVisual® micropolymer detection system and
Ancillaries supporting reagents to deliver a complete IHC solution.
Contact us to request catalogs, sample testing, or technical consultation.
Product List
